From: Modulations of cell cycle checkpoints during HCV associated disease
 | Mean Age (years) | Gender (male/female) | Virus infection | *Stage of Fibrosis | *Grade of Inflammation |
---|---|---|---|---|---|
a) Patients included in PCR array experiments | |||||
Early HCV (n = 4) | 40 ± 6.2 | 2/2 | HCV | 0–1 | 0–1 |
Advanced HCV (n = 4) | 53 ± 4.9 | 2/2 | HCV | 3–4 | 3–4 |
b) Patients included in Immunohistochemistry experiments | |||||
Chronic HCV (n = 38) | 42+9.3 | 18/20 | HCV | 0–4 | 1–4 |
Non-viral hepatitis (n = 6) | 49 ± 2.1 | 2/4 | None | 1–4 | 1–3 |
Normal (n = 4) | 26 ± 4.0 | 2/2 | None | - | - |